Severe dengue: questioning the paradigm

Microbes and Infection

Volumn 12, Issue 2, 2010, Pages 113-118

  Murgue, Bernadette ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AEDES AEGYPTI; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; DISEASE TRANSMISSION; EPIDEMIC; FATALITY; HUMAN; INCIDENCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SYMPTOM; VIRUS STRAIN; VIRUS VIRULENCE;

DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 75149175533     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.11.006     Document Type: Short Survey

References (55)

1. Gubler D.J., and Kuno G. Dengue and dengue hemorrhagic fever (1997), CAB International, Wallingford, Oxon, UK, New York
2. Papaevangelou G., and Halstead S.B. Infections with two dengue viruses in Greece in the 20th century. Did dengue hemorrhagic fever occur in the 1928 epidemic?. The Journal of Tropical Medicine and Hygiene 80 (1977) 46-51
3. Hammon W.M., Rudnick A., Sather G., Rogers K.D., and Morse L.J. New hemorrhagic fevers of children in the Philippines and Thailand. Transactions of the Association of American Physicians 73 (1960) 140-155
4. WHO (Ed.), Technical guidelines for diagnosis, treatment and control, 1997.
5. Halstead S.B., and O'Rourke E.J. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265 (1977) 739-741
6. Kurane I., Innis B.L., Nimmannitya S., Nisalak A., Rothman A.L., Livingston P.G., Janus J., and Ennis F.A. Human immune responses to dengue viruses. The Southeast Asian Journal of Tropical Medicine and Public Health 21 (1990) 658-662
7. Halstead S.B., Casals J., Shotwell H., and Palumbo N. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections. The American Journal of Tropical Medicine and Hygiene 22 (1973) 365-374
8. Barnes W.J., and Rosen L. Fatal hemorrhagic disease and shock associated with primary dengue infection on a Pacific island. The American Journal of Tropical Medicine and Hygiene 23 (1974) 495-506
9. Kuberski T., Rosen L., Reed D., and Mataika J. Clinical and laboratory observations on patients with primary and secondary dengue type 1 infections with hemorrhagic manifestations in Fiji. The American Journal of Tropical Medicine and Hygiene 26 (1977) 775-783
10. Scott R.M., Nimmannitya S., Bancroft W.H., and Mansuwan P. Shock syndrome in primary dengue infections. The American Journal of Tropical Medicine and Hygiene 25 (1976) 866-874
11. Rosen L. Dengue in Greece in 1927 and 1928 and the pathogenesis of dengue hemorrhagic fever: new data and a different conclusion. The American Journal of Tropical Medicine and Hygiene 35 (1986) 642-653
12. George R., and Lum L. Clinical spectrum of dengue infection. In: Guubler D., and Kuno G. (Eds). Dengue and dengue hemorrhagic fever (1997), CAB International, Wallingford, UK 89-114
13. Murgue B., Deparis X., Chungue E., Cassar O., and Roche C. Dengue: an evaluation of dengue severity in French Polynesia based on an analysis of 403 laboratory-confirmed cases. Trop Med Int Health 4 (1999) 765-773
14. Phuong C.X., Nhan N.T., Kneen R., Thuy P.T., van Thien C., Nga N.T., Thuy T.T., Solomon T., Stepniewska K., and Wills B. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful?. The American Journal of Tropical Medicine and Hygiene 70 (2004) 172-179
15. Harris E., Videa E., Perez L., Sandoval E., Tellez Y., Perez M.L., Cuadra R., Rocha J., Idiaquez W., Alonso R.E., Delgado M.A., Campo L.A., Acevedo F., Gonzalez A., Amador J.J., and Balmaseda A. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. The American Journal of Tropical Medicine and Hygiene 63 (2000) 5-11
16. Balmaseda A., Hammond S.N., Perez M.A., Cuadra R., Solano S., Rocha J., Idiaquez W., and Harris E. Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. The American Journal of Tropical Medicine and Hygiene 73 (2005) 1059-1062
17. Souza L.J., Alves J.G., Nogueira R.M., Gicovate Neto C., Bastos D.A., Siqueira E.W., Souto Filho J.T., Cezario Tde A., Soares C.E., and Carneiro Rda C. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. The Brazilian journal of infectious diseases 8 (2004) 156-163
18. Domingues R.B., Kuster G.W., Onuki-Castro F.L., Souza V.A., Levi J.E., and Pannuti C.S. Involvement of the central nervous system in patients with dengue virus infection. Journal of the neurological sciences (2007)
19. Solomon T., Dung N.M., Vaughn D.W., Kneen R., Thao L.T., Raengsakulrach B., Loan H.T., Day N.P., Farrar J., Myint K.S., Warrell M.J., James W.S., Nisalak A., and White N.J. Neurological manifestations of dengue infection. Lancet 355 (2000) 1053-1059
20. Wang C.C., Liu S.F., Liao S.C., Lee I.K., Liu J.W., Lin A.S., Wu C.C., Chung Y.H., and Lin M.C. Acute respiratory failure in adult patients with dengue virus infection. The American Journal of Tropical Medicine and Hygiene 77 (2007) 151-158
21. Obeyesekere I., and Hermon Y. Arbovirus heart disease: myocarditis and cardiomyopathy following dengue and chikungunya fever - a follow-up study. American heart journal 85 (1973) 186-194
22. Wiersinga W.J., Scheepstra C.G., Kasanardjo J.S., de Vries P.J., Zaaijer H., and Geerlings S.E. Dengue fever-induced hemolytic uremic syndrome. Clinical infectious diseases 43 (2006) 800-801
23. Derycke T., Levy P., Genelle B., Ruszniewski P., and Merzeau C. Acute pancreatitis secondary to dengue. Gastroenterologie Clinique et Biologique 29 (2005) 85-86
24. Chan D.P., Teoh S.C., Tan C.S., Nah G.K., Rajagopalan R., Prabhakaragupta M.K., Chee C.K., Lim T.H., and Goh K.Y. Ophthalmic complications of dengue. Emerging Infectious Diseases 12 (2006) 285-289
25. de Oliveira S.A., Camacho L.A., Bettini L.R., Fernandes D.G., Gouvea N.A., Barros R.A., Setubal S., and Siqueira M.M. The joint manifestations of exanthematous viroses. Revista da Sociedade Brasileira de Medicina Tropical 32 (1999) 125-130
26. Seet R.C., Quek A.M., and Lim E.C. Post-infectious fatigue syndrome in dengue infection. Journal of clinical virology 38 (2007) 1-6
27. Deen J.L., Harris E., Wills B., Balmaseda A., Hammond S.N., Rocha C., Dung N.M., Hung N.T., Hien T.T., and Farrar J.J. The WHO dengue classification and case definitions: time for a reassessment. Lancet 368 (2006) 170-173
28. Setiati T.E., Mairuhu A.T., Koraka P., Supriatna M., Mac Gillavry M.R., Brandjes D.P., Osterhaus A.D., van der Meer J.W., van Gorp E.C., and Soemantri A. Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system. BMC Infectious Diseases 7 (2007) 22
29. Suwandono A., Kosasih H., Nurhayati, Kusriastuti R., Harun S., Ma'roef C., Wuryadi S., Herianto B., Yuwono D., Porter K.R., Beckett C.G., and Blair P.J. Four dengue virus serotypes found circulating during an outbreak of dengue fever and dengue haemorrhagic fever in Jakarta, Indonesia, during 2004. Transactions of the Royal Society of Tropical Medicine and Hygiene 100 (2006) 855-862
30. Nogueira R.M., Miagostovich M.P., Cunha R.V., Zagne S.M., Gomes F.P., Nicol A.F., Coelho J.C., and Schatzmayr H.G. Fatal primary dengue infections in Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene 93 (1999) 418
31. Laoprasopwattana K., Libraty D.H., Endy T.P., Nisalak A., Chunsuttiwat S., Vaughn D.W., Reed G., Ennis F.A., Rothman A.L., and Green S. Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. The Journal of Infectious Diseases 192 (2005) 510-519
32. Sun W., Nisalak A., Gettayacamin M., Eckels K.H., Putnak J.R., Vaughn D.W., Innis B.L., Thomas S.J., and Endy T.P. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination. The Journal of Infectious Diseases 193 (2006) 1658-1665
33. Huang K.J., Li S.Y., Chen S.C., Liu H.S., Lin Y.S., Yeh T.M., Liu C.C., and Lei H.Y. Manifestation of thrombocytopenia in dengue-2-virus-infected mice. The Journal of General Virology 81 (2000) 2177-2182
34. Johnson A.J., and Roehrig J.T. New mouse model for dengue virus vaccine testing. Journal of Virology 73 (1999) 783-786
35. Bente D.A., Melkus M.W., Garcia J.V., and Rico-Hesse R. Dengue fever in humanized NOD/SCID mice. Journal of Virology 79 (2005) 13797-13799
36. Shresta S., Sharar K.L., Prigozhin D.M., Beatty P.R., and Harris E. Murine model for dengue virus-induced lethal disease with increased vascular permeability. Journal of Virology 80 (2006) 10208-10217
37. Kyle J.L., Beatty P.R., and Harris E. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. The Journal of Infectious Diseases 195 (2007) 1808-1817
38. Wu S.J., Grouard-Vogel G., Sun W., Mascola J.R., Brachtel E., Putvatana R., Louder M.K., Filgueira L., Marovich M.A., Wong H.K., Blauvelt A., Murphy G.S., Robb M.L., Innes B.L., Birx D.L., Hayes C.G., and Frankel S.S. Human skin Langerhans cells are targets of dengue virus infection. Nature Medicine 6 (2000) 816-820
39. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trumpfheller C., Finke J., Sun W., Eller M.A., Pattanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., and Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. The Journal of Experimental Medicine 197 (2003) 823-829
40. Navarro-Sanchez E., Altmeyer R., Amara A., Schwartz O., Fieschi F., Virelizier J.L., Arenzana-Seisdedos F., and Despres P. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Reports 4 (2003) 723-728
41. Cambi A., Koopman M., and Figdor C.G. How C-type lectins detect pathogens. Cell Microbiol 7 (2005) 481-488
42. Jessie K., Fong M.Y., Devi S., Lam S.K., and Wong K.T. Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. The Journal of Infectious Diseases 189 (2004) 1411-1418
43. Murgue B., Roche C., Chungue E., and Deparis X. Prospective study of the duration and magnitude of viraemia in children hospitalised during the 1996-1997 dengue-2 outbreak in French Polynesia. Journal of Medical Virology 60 (2000) 432-438
44. Libraty D.H., Endy T.P., Houng H.S., Green S., Kalayanarooj S., Suntayakorn S., Chansiriwongs W., Vaughn D.W., Nisalak A., Ennis F.A., and Rothman A.L. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. The Journal of Infectious Diseases 185 (2002) 1213-1221
45. Rico-Hesse R., Harrison L.M., Salas R.A., Tovar D., Nisalak A., Ramos C., Boshell J., de Mesa M.T., Nogueira R.M., and da Rosa A.T. Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230 (1997) 244-251
46. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., de C., Ramos C., and Rico-Hesse R. Dengue virus structural differences that correlate with pathogenesis. Journal of Virology 73 (1999) 4738-4747
47. Roche C., Cassar O., Laille M., and Murgue B. Dengue-3 virus genomic differences that correlate with in vitro phenotype on a human cell line but not with disease severity. Microbes and infection/Institut Pasteur 9 (2007) 63-69
48. Murgue B., Cassar O., Guigon M., and Chungue E. Dengue virus inhibits human hematopoietic progenitor growth in vitro. The Journal of Infectious Diseases 175 (1997) 1497-1501
49. Sakuntabhai A., Turbpaiboon C., Casademont I., Chuansumrit A., Lowhnoo T., Kajaste-Rudnitski A., Kalayanarooj S.M., Tangnararatchakit K., Tangthawornchaikul N., Vasanawathana S., Chaiyaratana W., Yenchitsomanus P.T., Suriyaphol P., Avirutnan P., Chokephaibulkit K., Matsuda F., Yoksan S., Jacob Y., Lathrop G.M., Malasit P., Despres P., and Julier C. A variant in the CD209 promoter is associated with severity of dengue disease. Nature genetics 37 (2005) 507-513
50. Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comparative immunology, microbiology and infectious diseases 30 (2007) 329-340
51. Murgue B., Cassar O., and Deparis X. Plasma concentrations of sVCAM-1 and severity of dengue infections. Journal of Medical Virology 65 (2001) 97-104
52. Koraka P., Murgue B., Deparis X., Van Gorp E.C., Setiati T.E., Osterhaus A.D., and Groen J. Elevation of soluble VCAM-1 plasma levels in children with acute dengue virus infection of varying severity. Journal of Medical Virology 72 (2004) 445-450
53. Chen L.C., Lei H.Y., Liu C.C., Shiesh S.C., Chen S.H., Liu H.S., Lin Y.S., Wang S.T., Shyu H.W., and Yeh T.M. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. The American Journal of Tropical Medicine and Hygiene 74 (2006) 142-147
54. Srikiatkhachorn A., Ajariyakhajorn C., Endy T.P., Kalayanarooj S., Libraty D.H., Green S., Ennis F.A., and Rothman A.L. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. Journal of Virology 81 (2007) 1592-1600
55. Luplertlop N., Misse D., Bray D., Deleuze V., Gonzalez J.P., Leardkamolkarn V., Yssel H., and Veas F. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Reports 7 (2006) 1176-1181